<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01761955</url>
  </required_header>
  <id_info>
    <org_study_id>J2008:075</org_study_id>
    <nct_id>NCT01761955</nct_id>
  </id_info>
  <brief_title>Metabolic Health Benefits of Dairy Protein</brief_title>
  <official_title>Metabolic Health Benefits of Dairy Protein</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of regular low fat diary consumption on&#xD;
      markers of cardiovascular (CV) and metabolic (cardiometabolic) health including body&#xD;
      composition (% body fat, body weight), blood lipids, blood glucose, arterial compliance,&#xD;
      blood pressure, insulin sensitivity and resting metabolic rate.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-centre, randomized, dietary intervention study of 12 months. A total of 100&#xD;
      overweight/obese individuals will be recruited, half recruited in Adelaide, South Australia&#xD;
      and the other half from Manitoba, Canada. At baseline, subjects assigned to HD will be given&#xD;
      standard serves of low fat dairy products (eg. 250mL milk, 200g yoghurt) on a regular basis&#xD;
      for 6 months and asked to incorporate 4 serves/day into their diet. Volunteers randomized to&#xD;
      the LD will be asked to continue with their habitual diet and consume less than 2 serves of&#xD;
      dairy on a regular basis for 6 months. All participants will be asked to complete a food&#xD;
      frequency questionnaire, physical activity diary, 3-day food record, and keep a record of&#xD;
      dairy serves (food log) consumed each day. In total, participants will be asked to come to&#xD;
      the centre 5 times throughout the study. However, the HD group will be asked to return to the&#xD;
      centre every two weeks to receive diary product and return dairy record (food log). At&#xD;
      baseline subjects will be asked to attend the Richardson Centre for Functional Foods and&#xD;
      Nutraceuticals (RCFFN) fasted for various measurements including: body weight, blood&#xD;
      pressure, arterial compliance, dual energy x-ray absorptiometry (DEXA) scan for measurement&#xD;
      of body fat, abdominal fat and bone mineral density, waist and hip circumferences and provide&#xD;
      a blood sample for the measurement of blood lipids, insulin and glucose.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>markers of metabolic (cardiometabolic) health</measure>
    <time_frame>Six Months</time_frame>
    <description>total body composition (% body fat)&#xD;
blood lipids, blood glucose&#xD;
blood pressure&#xD;
insulin sensitivity&#xD;
resting metabolic rate</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Hyperlipidemia</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>High Dairy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consuming four or more servings of dairy per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control, Low Dairy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants consumed less than 2 servings of low fat dairy per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Dairy</intervention_name>
    <description>Consuming 4 or more servings of dairy products per day for a period of 6 months</description>
    <arm_group_label>High Dairy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI ≥25 kg/m2, assessed as age-related healthy based on pre-study screening&#xD;
             examination including:&#xD;
&#xD;
               -  medical history&#xD;
&#xD;
               -  diet and lifestyle history&#xD;
&#xD;
               -  physical measurements (height, weight and blood pressure).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or likely to be pregnant (ionizing radiation from DEXA)&#xD;
&#xD;
          -  Weight ≥135kg (exceeds the capacity of the DEXA scanner)diagnosed diabetes or&#xD;
             cardiovascular disease&#xD;
&#xD;
          -  Liver or renal disease&#xD;
&#xD;
          -  Regular use of appetite suppressants&#xD;
&#xD;
          -  Irregular use of other treatments which might interfere with the outcomes of the study&#xD;
             (e.g anti-hypertensives, statins, thyroxine, omega-3 supplements etc).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Curtis Rempel, PhD, MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gary Fulcher, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter JH Jones, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rotimi Aluko, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Netticadan, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Richardson Centre for Functional Foods and Nutraceuticals</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3T 2N2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2008</verification_date>
  <study_first_submitted>May 22, 2012</study_first_submitted>
  <study_first_submitted_qc>January 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2013</study_first_posted>
  <last_update_submitted>January 9, 2013</last_update_submitted>
  <last_update_submitted_qc>January 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>body weight</keyword>
  <keyword>lipids</keyword>
  <keyword>glucose</keyword>
  <keyword>insulin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

